13F Pro Quality Score

37.9/100

Rank #2,215 of 2,960 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

17.8/100

Profitability

22.5/100

Balance Sheet

23.3/100

Earnings Quality

60.4/100

Free Cash Flow

33.7/100

Institutional Flow

3.7/100

Revenue Scale

79.8/100

Dilution Risk

73.2/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

HUN Stock Analysis & AI Quality Score

Data updated 2026-09-12

AI stock analysis and institutional research for Huntsman CORP (HUN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HUN at 37.9/100 on a 32-signal composite quality model, placing it at rank #2,215 of 2,960 stocks — the bottom half of the AI-ranked universe. HUN scores in the top quartile across revenue scale (79.8). Areas of concern include institutional flow (3.7) and revenue growth (17.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Huntsman CORP reports quarterly revenue of $1.4B, net income of $-53.0M, an operating margin of -1.1%. Top institutional holders of HUN by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, AQR CAPITAL MANAGEMENT, based on the most recent SEC filings. HUN trades on the NYSE exchange and files with the SEC under CIK 1307954. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HUN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Huntsman CORP directly from SEC EDGAR. Huntsman CORP's 13F Pro composite quality score has ranged between 33 and 67 since 2021, currently 37.9 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

Fun facts about Huntsman CORP

Quirks, history, and lore behind HUN — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. specialty chemicals company · mid-cap · listed on NYSE · headquartered in Texas.
  • 2
    The Numbers
    Annual revenue in the range of $6–8 billion, with operations spanning more than 30 countries — chemicals really do go everywhere.
  • 3
    The History
    Founded in the 1970s by a prominent American business family, it grew through aggressive acquisitions into one of the world's largest producers of MDI-based polyurethanes.
  • 4
    The Secret
    Its products hide inside things you touch every day — foam insulation, mattresses, car seats, and coatings — yet almost nobody knows its name.
  • 5
    The Lore
    The founding family is also famous for owning the Utah Jazz NBA franchise and building a cancer research institute — philanthropy on a billionaire scale.
  • 6
    The Giveaway
    Named after its billionaire founder Jon, this Texas-based chemicals giant is the world's largest maker of differentiated MDI polyurethanes — and the family name is impossible to miss on the ticker.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$1.4B

Net Income

Q1 2026

$-53.0M

Free Cash Flow

Q1 2026

$-91.0M

Operating Margin

Q1 2026

-1.1%

ROIC

Q1 2026

-1.3%

D/E Ratio

Q1 2026

0.91

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-5.8% YoY
$5.68BFY 2025
FY22 $8.02BFY23 $6.11BFY24 $6.04BFY25 $5.68B

Net Income

-50.3% YoY
$-284.0MFY 2025
FY22 $460.0MFY23 $101.0MFY24 $-189.0MFY25 $-284.0M

Operating Income

-424.0% YoY
$-131.0MFY 2025
FY22 $672.0MFY23 $84.0MFY24 $-25.0MFY25 $-131.0M

EPS (Diluted)

-50.0% YoY
$-1.65FY 2025
FY22 $2.27FY23 $0.57FY24 $-1.10FY25 $-1.65

Total Assets

-1.4% YoY
$7.01BFY 2025
FY22 $8.22BFY23 $7.25BFY24 $7.11BFY25 $7.01B

Total Debt

+9.4% YoY
$2.36BFY 2025
FY22 $1.80BFY23 $1.70BFY24 $2.16BFY25 $2.36B

Op. Cash Flow

+9.9% YoY
$289.0MFY 2025
FY22 $914.0MFY23 $209.0MFY24 $263.0MFY25 $289.0M

Free Cash Flow

+46.8% YoY
$116.0MFY 2025
FY22 $642.0MFY23 $-21.0MFY24 $79.0MFY25 $116.0M

Get alerted when HUN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Huntsman CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of HUN

Companies Similar to HUN

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

PRGO

PERRIGO Co plc

33
AI score
Similar quality profile · 13 shared holders
ACH

ACCENDRA HEALTH INC/VA/

29
AI score
Similar quality profile · 4 shared holders
MOH

MOLINA HEALTHCARE, INC.

52
AI score
Similar quality profile · 9 shared holders
IART

INTEGRA LIFESCIENCES HOLDINGS CORP

45
AI score
Similar quality profile · 7 shared holders
AHCO

AdaptHealth Corp.

43
AI score
Similar quality profile · 4 shared holders
XRAY

DENTSPLY SIRONA Inc.

38
AI score
Similar quality profile · 16 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put HUN on your watchlist

Track score changes the day Huntsman CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HUN a good stock to buy?

13F Pro's AI-powered analysis of Huntsman CORP (HUN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HUN are available on the HUN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. HUN is classified as a small company.

Which hedge funds own HUN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HUN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Huntsman CORP's investment landscape.